Atossa Therapeutics, Inc. · NASDAQ:ATOS
Atossa Therapeutics, Inc. shareholders
As of Jun 30, 2026, 30 institutions reported holding Atossa Therapeutics, Inc., 13.5% of its shares. Largest: Vanguard, Ameriprise and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Atossa Therapeutics, Inc. | Change | Filed |
|---|---|---|---|---|
| Vanguard | 417K | 4.2% | +12,999 | Aug 13, 2026 |
| Ameriprise | 258K | 2.6% | +3,100 | Aug 14, 2026 |
| BlackRock | 164K | 1.6% | +31,189 | Aug 7, 2026 |
| Renaissance Technologies | 132K | 1.3% | +23,036 | Aug 13, 2026 |
| Geode Capital | 92,382 | 0.93% | −4,679 | Aug 12, 2026 |
| UBS | 82,620 | 0.83% | −9,414 | Aug 13, 2026 |
| Jane Street | 56,602 | 0.57% | new | Aug 14, 2026 |
| Millennium | 46,508 | 0.47% | −20,231 | Aug 14, 2026 |
| State Street | 39,761 | 0.40% | no change | Aug 7, 2026 |
| Northern Trust | 20,249 | 0.20% | +1,025 | Aug 13, 2026 |